23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

Catharina Barkman: Health gains that transform lives and economies

Novo Nordisk has not only transformed obesity treatment but also made its mark on Denmark’s economy. Sweden has a long history of medical innovation, but how can we create the conditions for the next major success? Catharina Barkman explores the question in her latest column.
Advertisement

Around 14 per cent of Sweden’s population lives with obesity, and just over half are overweight or obese. Obesity increases the risk of diabetes, cardiovascular disease and certain types of cancer, among other conditions. In 2023, the costs to society were estimated at SEK 80–125 billion, according to IHE and the Swedish Public Health Agency, respectively.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.063|